CoreyCasperMDMPH
Infectious Disease • Seattle, WAChief Executive Officer, Access to Advanced Health Institute Clinical Professor of Medicine and Global Health, University of Washington Affiliate Member, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center
Dr. Casper is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1616 Eastlake Ave E
Suite 400
Seattle, WA 98102Phone+1 206-858-6054Fax+1 206-858-6298
Summary
Education & Training
University of WashingtonFellowship, Infectious Disease, 2000 - 2003
University of California (San Francisco)Residency, Internal Medicine, 1997 - 2000
Weill Cornell MedicineClass of 1997
Certifications & Licensure
CA State Medical License 1998 - Present
WA State Medical License 2000 - 2025- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Safety, Tolerability, and Immunogenicity of CRV-101 in Healthy Adult Subjects Start of enrollment: 2019 Jan 03
Publications & Presentations
PubMed
- 34 citationsHIV-specific CD8+ T cells from HIV+ individuals receiving HAART can be expanded ex vivo to augment systemic and mucosal immunity in vivo.Aude G. Chapuis, Corey Casper, Steve Kuntz, Jia Zhu, Annelie Tjernlund
Blood. 2011-05-19 - 225 citationsInternational, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman diseaseFrits van Rhee, Peter M. Voorhees, Angela Dispenzieri, Alexander Fosså, Gordan Srkalovic
Blood. 2018-11-15 - 331 citationsInternational, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman diseaseDavid C. Fajgenbaum, Thomas S. Uldrick, Adam Bagg, Dale Frank, David Wu
Blood. 2017-03-23
Journal Articles
- Quantitative RNAseq Analysis of Ugandan KS Tumors Reveals KSHV Gene Expression Dominated by Transcription from the LTd Downstream Latency PromoterWarren Phipps, Timothy M Rose, Corey Casper, PLoS One
- International, Evidence-Based Consensus Treatment Guidelines for Idiopathic Multicentric Castleman DiseaseAaron Goodman, Corey Casper, Sudipto Mukherjee, Peter Voorhees, Angela Dispenzieri, David C Fajgenbaum, Amy Chadburn, Razelle Kurzrock, Raj Jayanthan, Sunita Nasta, Th..., Blood
Abstracts/Posters
- Natural History Study of Idiopathic Multicentric Castleman Disease Identifies Effective Treatments for a Large Proportion of Patients but Treatment-Refractory Patients...Corey Casper, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Other
- Diagnosis and antiviral therapy of human herpesvirus 8 infectionCasper C
http://www.uptodate.com/contents/diagnosis-and-antiviral-therapy-of-human-herpesvirus-8-infection
UpToDate, Wolters Kluwer Health - 2012-10-11 - Disease associations of human herpesvirus 8 infectionCasper C
http://www.uptodate.com/contents/disease-associations-of-human-herpesvirus-8-infection
UpToDate, Wolters Kluwer Health - 2012-09-14 - Virology, epidemiology, and transmission of human herpesvirus 8 infectionCasper C
http://www.uptodate.com/contents/virology-epidemiology-and-transmission-of-human-herpesvirus-8-infec
UpToDate, Wolters Kluwer Health - 2012-09-18
Press Mentions
Thermostable TB Vaccine Found Safe and Immunogenic in HumansMarch 7th, 2023- The Access to Advanced Health Institute Reports Encouraging Results of First-in-Human Trial of Its Temperature-Stable Tuberculosis Vaccine CandidateMarch 6th, 2023
- The Access to Advanced Health Institute Develops Longer Lasting and Broadly Protective SARS-CoV-2 RNA Vaccine Candidate That Is Stable at Room TemperatureNovember 3rd, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
